1. Home
  2. CINGW vs POWWP Comparison

CINGW vs POWWP Comparison

Compare CINGW & POWWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • POWWP
  • Stock Information
  • Founded
  • CINGW N/A
  • POWWP N/A
  • Country
  • CINGW United States
  • POWWP United States
  • Employees
  • CINGW 13
  • POWWP 342
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • POWWP Ordnance And Accessories
  • Sector
  • CINGW Health Care
  • POWWP Industrials
  • Exchange
  • CINGW Nasdaq
  • POWWP Nasdaq
  • Market Cap
  • CINGW N/A
  • POWWP N/A
  • IPO Year
  • CINGW 2021
  • POWWP N/A
  • Fundamental
  • Price
  • CINGW $0.06
  • POWWP $22.15
  • Analyst Decision
  • CINGW
  • POWWP
  • Analyst Count
  • CINGW 0
  • POWWP 0
  • Target Price
  • CINGW N/A
  • POWWP N/A
  • AVG Volume (30 Days)
  • CINGW N/A
  • POWWP N/A
  • Earning Date
  • CINGW N/A
  • POWWP N/A
  • Dividend Yield
  • CINGW N/A
  • POWWP N/A
  • EPS Growth
  • CINGW N/A
  • POWWP N/A
  • EPS
  • CINGW N/A
  • POWWP N/A
  • Revenue
  • CINGW N/A
  • POWWP N/A
  • Revenue This Year
  • CINGW N/A
  • POWWP N/A
  • Revenue Next Year
  • CINGW N/A
  • POWWP N/A
  • P/E Ratio
  • CINGW N/A
  • POWWP N/A
  • Revenue Growth
  • CINGW N/A
  • POWWP N/A
  • 52 Week Low
  • CINGW N/A
  • POWWP N/A
  • 52 Week High
  • CINGW N/A
  • POWWP N/A
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • POWWP 63.55
  • Support Level
  • CINGW N/A
  • POWWP $21.00
  • Resistance Level
  • CINGW N/A
  • POWWP $22.99
  • Average True Range (ATR)
  • CINGW 0.00
  • POWWP 1.09
  • MACD
  • CINGW 0.00
  • POWWP 0.15
  • Stochastic Oscillator
  • CINGW 0.00
  • POWWP 93.87

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About POWWP AMMO Inc. 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock

AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.

Share on Social Networks: